First Trust Capital Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
First Trust Capital Management's ARNA Position: Q1 2022 in Review
First Trust Capital Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 78,199 shares — an estimated $7.27M sold.
First Trust Capital Management first reported a position in ARNA in Q4 2021 and held it in 1 quarter. The position peaked at $7.27M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- First Trust Capital Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- First Trust Capital Management sold 78,199 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $7.27M.
- First Trust Capital Management first reported a position in Arena Pharmaceuticals Inc in Q4 2021 and held it in 1 quarter.
- First Trust Capital Management's Arena Pharmaceuticals Inc position peaked at $7.27M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on First Trust Capital Management's 13F filing for Q1 2022, filed 16 May 2022.